Alvo Minerals finds itself a new Brazilian target - Stocks Down Under
9 hours ago • Google News
Alvotech (ALVO)
US$ 8.78997.19%
Price Chart
Key Statistics
Market Cap
$ 2.92B
P/E Ratio
0.00
Revenue (TTM)
$ 491.98M
Volume
106.26K
52W High
$ 10.40
52W Low
$ 7.90
Dividend Yield
0.00%
Beta
-0.02
Technicals
50-Day MA
9.6148
200-Day MA
11.5103
52 Week High
10.4
52 Week Low
7.9
About ALVO
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders.
Employees
1012
Headquarters
Luxembourg, Luxembourg
CEO
Mr. Robert Wessman
Latest News
Is Alvotech (ALVO) The Best Stock That Will Bounce Back? - Yahoo Finance
3 days ago • Google News
Alvo Minerals Updates Presentation for RIU Conference - TipRanks
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg